Acute coronary syndromes in Europe: 1-year costs and outcomes

Authors: Taylor, Matthew J.¹; Scuffham, Paul A.²; McCollam, Patrick L.³; Newby, David E.⁴

Source: Current Medical Research and Opinion, Volume 23, Number 3, March 2007 , pp. 495-503(9)

Buy & download fulltext article:

Price: $51.50 plus tax (Refund Policy)

Abstract:

Objective: This study aims to estimate costs (including medications prescribed, intervention rates and hospital utilization) and health outcomes of acute coronary syndromes (ACS) during the first year following diagnosis.

Research design and methods: Treatment pathways for ACS patients were developed and country-specific resource use was multiplied by unit costs. Countries examined were the United Kingdom (UK), France, Germany, Italy and Spain. Patients with unstable angina and acute myocardial infarction (ST-segment elevation and non-ST-segment elevation with/without Q-wave) were considered. The study models the incidence of ACS, 1-year mortality, investigations, revascularisation, pharmaceutical use and medical management. Economic outcomes were direct healthcare costs (in 2004 Euros), including total cost, cost per patient with ACS and cost per capita.

Results: The estimated number of deaths in the first year following ACS diagnosis ranged from around 22 500 in Spain to over 90 000 in Germany. The largest contributors to total costs are hospital stay and revascularisation procedures. Pharmaceuticals were estimated at 14-25% of ACS total cost. The total cost of ACS in the UK is estimated around €1.9 billion, compared with €1.3 billion in France, €3.3 billion in Germany, €3.1 billion in Italy and €1.0 billion in Spain. The cost per ACS patient ranges from €7009 (in the UK) to €12 086 (Italy).

Conclusions: Countries with higher expenditure on ACS patients tended to have lower case-fatality rates, and countries with the lowest incidence of ACS also had the lowest cost per capita. The costs of ACS constitute a large proportion of total healthcare expenditure of Western European economies.

Keywords: ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL INFARCTION; COST OF ILLNESS; EUROPE; UNSTABLE ANGINA

Document Type: Research article

DOI: http://dx.doi.org/10.1185/030079906X167462

Affiliations: 1: Senior Consultant, York Health Economics Consortium Ltd, University of York, UK 2: Associate Senior Consultant, York Health Economics Consortium, University of York, UK; Professor of Health Economics, School of Medicine, Griffith University, Queensland, Australia 3: Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA 4: Professor of Cardiology and Consultant Cardiologist, University of Edinburgh, UK

Publication date: 2007-03-01

More about this publication?

Information for Authors
Subscribe to this Title
Terms & Conditions
General Information
Journal Information
ingentaconnect is not responsible for the content or availability of external websites

Acute coronary syndromes in Europe: 1-year costs and outcomes

Buy & download fulltext article:

Tools

Key

Text size:

Useful pages